HPV Prevalence and Type Distribution in Women With Normal or Abnormal Pap Smear in Bulgaria

被引:9
作者
Grozdanov, Peter [1 ]
Zlatkov, Victor [2 ]
Ganchev, Gancho [3 ]
Karagiosov, Ilko [4 ]
Toncheva, Draga [5 ]
Galabov, Angel S. [1 ]
机构
[1] Bulgarian Acad Sci, Dept Virol, Stephan Angeloff Inst Microbiol, Sofia, Bulgaria
[2] Gynecol & Obstet Majchin Dom Hosp, Sofia, Bulgaria
[3] Natl Inst Oncol & Hematol, Sofia, Bulgaria
[4] Tokuda Hosp, Sofia, Bulgaria
[5] Med Univ, Dept Med Genet, Sofia, Bulgaria
关键词
human papillomavirus; genotyping; linear array; abnormal Pap; cervical cancer; HPV vaccine; HUMAN-PAPILLOMAVIRUS TYPES; LINEAR-ARRAY; CANCER; PCR; PERFORMANCE; COLPOSCOPY; UTILITY; ASSAY; RISK; TIME;
D O I
10.1002/jmv.24020
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human papillomavirus (HPV) is a well-known pathogen for lower genital tract neoplasias, yet little is known regarding HPV prevalence in Bulgaria. The aim of this study was to investigate the prevalence of HPV DNA and to determine HPV types distribution among women with normal and abnormal cytology. Cervical smears with different cytological diagnoses were collected from 355 Bulgarian patients. The cohort of patients selected is the biggest ever studied in this country. Using the Roche Linear Array HPV Genotyping Test, papillomavirus DNA was found in 217 out of the 355 samples, 164 of which had only one and 53 had more than one HPV type. The distribution of the viruses tested in 355 samples was as follows: (i) the most common type was HPV 16, which was found in 61 samples; (ii) the next most frequent HPV type was HPV 33, found in 14 of the samples. A high prevalence of HPV infection was observed in this study. As HPV infection has a high correlation with cervical cancer, this study emphasizes the need for both primary prevention of cervical cancer with HPV vaccines as well as secondary prevention with screening. Currently, two HPV vaccines are included in the National immunization schedule in Bulgaria. Thus, new clinical studies will benefit from patient stratification by the presence or absence of HPV, and by designing separate clinical trials specifically for HPV associated cancers. J. Med. Virol. 86:1905-1910, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1905 / 1910
页数:6
相关论文
共 31 条
  • [1] [Anonymous], B WHO BLT
  • [2] Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections
    Baleriola, Cristina
    Millar, Douglas
    Melki, John
    Coulston, Neralie
    Altman, Phillip
    Rismanto, Nikolas
    Rawlinson, William
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (01) : 22 - 26
  • [3] Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies
    Bernard, Erik
    Pons-Salort, Margarita
    Favre, Michel
    Heard, Isabelle
    Delarocque-Astagneau, Elisabeth
    Guillemot, Didier
    Thiebaut, Anne C. M.
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [4] A review of human carcinogens-Part B: biological agents
    Bouvard, Veronique
    Baan, Robert
    Straif, Kurt
    Grosse, Yann
    Secretan, Beatrice
    El Ghissassi, Fatiha
    Benbrahim-Tallaa, Lamia
    Guha, Neela
    Freeman, Crystal
    Galichet, Laurent
    Cogliano, Vincent
    [J]. LANCET ONCOLOGY, 2009, 10 (04) : 321 - 322
  • [5] Comparison of two PCR-based human papillomavirus genotyping methods
    Castle, Philip E.
    Porras, Carolina
    Quint, Wim G.
    Rodriguez, Ana Cecilia
    Schiffman, Mark
    Gravitt, Patti E.
    Gonzalez, Paula
    Katki, Hormuzd A.
    Silva, Sandra
    Freer, Enrique
    Van Doorn, Leen-Jan
    Jimenez, Silvia
    Herrero, Rolando
    Hildesheim, Allan
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (10) : 3437 - 3445
  • [6] Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
    Castle, Philip E.
    Stoler, Mark H.
    Wright, Thomas C., Jr.
    Sharma, Abha
    Wright, Teresa L.
    Behrens, Catherine M.
    [J]. LANCET ONCOLOGY, 2011, 12 (09) : 880 - 890
  • [7] Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit
    Dursun, Polat
    Senger, Sueheyla S.
    Arslan, Hande
    Kuscu, Esra
    Ayhan, Ali
    [J]. BMC INFECTIOUS DISEASES, 2009, 9
  • [8] Georgiev D, 2003, INT J GYNECOL OBSTET, V15, P131
  • [9] Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
    Gravitt, PE
    Peyton, CL
    Apple, RJ
    Wheeler, CM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 3020 - 3027
  • [10] Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357